Skip to main content

Condition · 2 treatment paths

Non-Hodgkin Lymphoma (DLBCL)

Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma, a cancer of B lymphocytes. It grows quickly but is often curable, and it mainly affects adults over 60.

Severe
Request opinion View roster

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Last updated: How we source & review

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
2Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About non-hodgkin lymphoma (dlbcl)

What to know

A painless swelling of lymph nodes in the neck, armpit or groin is common, sometimes with fever, night sweats and weight loss (B symptoms). Diagnosis requires a biopsy, followed by PET-CT, blood tests and sometimes bone marrow or spinal fluid tests to stage it. Without treatment it progresses over weeks to months, but many people reach remission with standard therapy.

First-line treatment is R-CHOP, chemotherapy combined with the antibody rituximab, with radiotherapy for selected bulky disease. If the lymphoma returns or does not respond, salvage chemotherapy with autologous stem cell transplant is used for fit patients. CAR-T cell therapy is an option after relapse or for refractory disease. Patients may travel to centres abroad for CAR-T or trials.

Pre-flight workup

Tests to have already done

  • Biopsy pathology report confirming DLBCL, including immunohistochemistry and, if done, tests for MYC, BCL2 and BCL6 rearrangements.
  • PET-CT scan reports, usually requested for staging and to assess treatment response.
  • Blood tests including LDH, blood counts, liver and kidney function, and hepatitis B and HIV screening.
  • Bone marrow biopsy or brain imaging results if they were performed.
  • Treatment records: regimen such as R-CHOP, number of cycles, doses, side effects, and response scans.
  • Heart function test such as an echocardiogram, especially before anthracycline chemotherapy or CAR-T.

Second opinion

When to get a second look

  • The pathology is unclear, or the lymphoma has high-risk features such as double-hit changes that may need a different plan.
  • The lymphoma has come back or not fully responded to first treatment, and CAR-T or transplant is being discussed.
  • You have been told treatment is palliative only, and want to confirm whether a curative option remains.
  • The lymphoma involves the brain or spinal fluid, or testicles, where specialist protocols apply.

Talking to your doctor

Questions to ask

  1. Is this DLBCL, and what are its subtype and genetic features?
  2. What is my stage and risk score (IPI), and how do they affect the plan?
  3. Which regimen do you recommend and how will response be checked, for example with an interim PET scan?
  4. If it does not respond or returns, what are the next options, including CAR-T?
  5. How will you protect my heart, fertility and infection risk during treatment?
  6. What follow-up and scanning schedule applies after treatment?

Outlook

Realistic prognosis

A large proportion of people with DLBCL are cured with first-line chemo-immunotherapy, particularly when disease is early stage and low risk. Outlook varies with stage, age, the International Prognostic Index, and genetic features such as double-hit lymphoma. If the lymphoma returns, salvage therapy with stem cell transplant or CAR-T can still lead to long-term remission for some people. Most relapses happen within the first two years.

01 · Specialties

Specialties that treat Non-Hodgkin

Specialists Doctors who treat non-hodgkin lymphoma (dlbcl) Cross-hospital roster across 1+ relevant specialties. View roster

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For non-hodgkin lymphoma (dlbcl), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

03 · Treatment paths

Treatment options

All treatments

Where to be treated

Non-Hodgkin Lymphoma (DLBCL) treatment by destination

Get a panel match

04 · FAQ

Common questions about non-hodgkin lymphoma (dlbcl)

Is DLBCL curable?

Yes, a large proportion of people are cured with first-line chemo-immunotherapy, particularly with early-stage and lower-risk disease. Curability depends on stage, age and genetic features.

What is CAR-T therapy?

It uses a patient's own T cells, modified to attack lymphoma cells. It is generally used when the lymphoma returns or does not respond to earlier treatment and needs a specialised centre.

How long does treatment take?

First-line treatment usually runs for about four to five months in cycles, followed by scans to check response. Relapse treatments take longer.

Clinical context

Working up non-hodgkin lymphoma (dlbcl) properly

A condition like non-hodgkin lymphoma (dlbcl) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
How this page is made

Methodology and editorial standards

This non-hodgkin lymphoma (dlbcl) overview is written by the editorial team from published Oncology sources and lists 2 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.
Data sources for this page
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Non-Hodgkin Lymphoma (DLBCL)

Continue evaluating non-hodgkin lymphoma (dlbcl) care

Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating non-hodgkin lymphoma (dlbcl).

Next step · Non-Hodgkin Lymphoma (DLBCL)

Free second opinion on your Non-Hodgkin case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.

Get a free quoteItemised quotes from accredited hospitals, free of charge Free second opinionA specialist reviews your reports Talk to a coordinatorWhatsApp, email or phone